Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 819-830

  Levy, Yair ^a,b   Tal, Noam ^a,b   Tzemach, Gilad ^b   Weinberger, Judah ^c   Domb, Abraham J ^b   Mandler, Daniel ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Elutex Ltd   (Israel)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adhesion promoter; Coating; Diazonium salt; Electrochemistry; Stent

Indexed keywords

ADHESION PROMOTER; ADHESION TEST; BASECOAT; DIAZONIUM SALT; DIAZONIUM SALTS; DRUG RELEASE; DRUG-ELUTING STENTS; ELECTROCHEMICAL TEST; ELECTROCOATINGS; IMPEDANCE SPECTROSCOPY; IN-VITRO; INERT PROPERTIES; INTRAVASCULAR; MANUFACTURING METHODOLOGY; MECHANICAL PROCESS; METALLIC STENTS; METALLIC SURFACE; ORGANIC RESIDUES; PEELING TEST; PHYSIOLOGICAL BUFFERS; POLYMER COATING; POLYMERIC COATINGS; POLYMERIC FILMS; POOR STABILITY; POTENTIAL HAZARDS; TETRAFLUOROBORATES;

ADHESION; ARTIFICIAL ORGANS; BIOCOMPATIBILITY; CHROMATOGRAPHIC ANALYSIS; COATINGS; CYCLIC VOLTAMMETRY; DURABILITY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTROLYSIS; MECHANICAL PROPERTIES; METALLIC COMPOUNDS; MULTILAYER FILMS; ORGANIC COMPOUNDS; PLASTIC COATINGS; POLYMERS; SCANNING ELECTRON MICROSCOPY; STABILITY; X RAY PHOTOELECTRON SPECTROSCOPY;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

ADHESIVE AGENT; C 12 PHENYLDIAZONIUM; DIAZONIUM COMPOUND; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; BARE METAL STENT; BIOCOMPATIBILITY; CYCLIC POTENTIOMETRY; CYTOTOXICITY; DRUG ELUTING STENT; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTROCHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; MICROSCOPY; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; X RAY PHOTOELECTRON SPECTROSCOPY;

ADHESIVENESS; ANGIOPLASTY, BALLOON; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZENE DERIVATIVES; BLOOD VESSELS; CELL ADHESION; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DIAZONIUM COMPOUNDS; DRUG-ELUTING STENTS; ELECTRIC IMPEDANCE; ELECTROCHEMISTRY; FULLERENES; HEMOLYSIS; MATERIALS TESTING; METALS; MICROSCOPY, ELECTRON, SCANNING; PACLITAXEL; POLYMERS; RABBITS; SPECTROMETRY, X-RAY EMISSION;

EID: 71649106715     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31461     Document Type: Article

References (31)

1. Hasebe T, Matsuoka Y, Kodama H, Saito T, Yohena S, Kamijo N, Shiraga N, Higuchi M, Kuribayahshi S, Takahashi K, Suzuki T. Lubrication performance of diamond-like carbon and fluorinated diamond-like carbon coatings for intravascular guidewires. Diamond Relat Mater 2006;15:129-132.
2. Santavirta S. Compatibility of the totally replaced hip. Reduction of wear by amorphous diamond coating. Acta Orthop Scand Suppl 2003;74:1-19.
3. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004;25:5681-5703.
4. Moro T, et al. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater 2004;3:829-836.
5. Saia F, Marzocchi A, Serruys PW. Drug-eluting stents: The third revolution in percutaneous coronary intervention. Ital Heart J 2005;6:289-303.
6. Ryan AJ, Cohen DJ. Will drug-eluting stents bankrupt the healthcare system? Circulation 2006;114:1736-1744.
7. USFDA. Summary of safety and effectiveness data. Cypher™ Sirolimus-eluting Coronary Stent on RAPTOR® Over-the-Wire Delivery System or RAPTORRAIL® Rapid Exchange Delivery System - P020026. 2003. Available at:http://www.fda.gov/cdrh/pdf2/p020026.html.
8. Belle EV, Susen S, Jude B, Bertrand ME. Drug eluting stents: Trading restenosis for thrombosis. J Thrombosis Haemostasis 2007;5:238-245. (Pubitemid 46958839)
9. Kim HL, Pakr KW, Kwak JJ, Kim YS, Sir JJ, Lee SJ, Lee HY, Chang HJ, Kang HJ, Cho YS, Chung WY, Chae IH, et al. Stent-related cardiac events after non-cardiac surgery: Drug-eluting stent vs. bare metal stent. Int J Cardiol 2008;123:353-354.
10. Sharifkazemi MB, Zamirian M, Aslani A. A current problem in cardiology: Very late thrombosis after implantation of sirolimus eluting stents. Cardiology 2007;108:273-274. (Pubitemid 350126470)
11. Ruchin PE, Muller DWM, Faddy SC, Baron DW, Roy PR, Wilson SH. Long-term clinical follow-up of sirolimus-eluting (cyphertm) coronary stents in the treatment of instent restenosis in an unselected population. Heart Lung Circ 2007;16:440-446. (Pubitemid 350091402)
12. Unger F. Drug-eluting stents a nightmare? Interactive Cardiovasc Thoracic Surg 2007;6:813-814.
13. Otsuka Y, Chronos NAF, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: Comparison of BiodivYsio, Taxus, and Cypher Stents. J Invasive Cardiol 2007;19:71-76.
14. Windecker S, Mierer B. Late coronary late thrombosis. Circulation. 2007;116:1952-1965.
15. Solttow TNO, Waksman R. Drug-eluting stent safety. Am J Cardiol 2007;100:10M-17M.
16. Sims J. Update on drug-eluting stents. Dimens Crit Care Nurs 2007;26:237-240.
17. Nakazawa G, Finn AV, Virmani R. Drug-eluting stent pathology - Should we still be cautious? Nat Clin Practice Cardiovasc Med 2008;5:1.
18. Austin D, Pell JP, Oldroyd KG. Drug-eluting stents: Do the risks really overweigh the benefits? Heart 2008;94:127-128.
19. Melikian N, Wijns W. Drug-eluting stent - A critique. Heart 2008;94:145-152.
20. Tesfamariam B. Local vascular toxicokinetics of stent-based drug delivery. Toxicol Lett 2007;168:93-102. (Pubitemid 46070206)
21. Ratner BD, Hoffman AS, Schoen FJ, Lemones JE. Biomaterials Science: An Introduction to Materials in Medicine. Amsterdam: Elsevier Academic Press; 1996.
22. Biocompatibility ISO files, 10993. Available at:http://www.iso.org.
23. Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006;58:387-401. (Pubitemid 43816741)
24. Wolgemuth L. The surface modification properties of parylene for medical applications. Medical Devices Manufacturing and Technologies. 2002;1-4.
25. Okner R, Domb AJ, Mandler D. Electrochemical formation and characterization of copolymers based on N-pyyrole derivatives. Biomolecules 2007;8:2928-2935. (Pubitemid 47516947)
26. Stern E, Jay S, Bertram J, Boese B, Kretzschmar I, Turner-Evans D, Dietz C, LaVan DA, Malinski T, Fahmy T, Reed MA. Electropolymerization on microelectrodes fictionalization technique for selective protein and DNA conjugation. Anal Chem 2006;78:6340-6346. (Pubitemid 44413583)
27. Allongue P, Delamar M, Desbat B, Fagebaume O, Hitmi R, Pinson J, Saveant JM. Covalent modification of iron surfaces by electrochemical reduction of aryldiazonium salts. J Am Chem Soc 2001;123:4541-4549. (Pubitemid 32923382)
28. Matrab T, Chancolon J, L'hermite MM, Rouzaud JN, Deniau G, Boudou GP, Chehimi MM, Delamar M. Atom transfer radical polymerization (ATRP) initiated by aryl diazonium salts: A new route for surface modification of multiwalled carbon nanotubes by tethered polymer chains. Colloids Surf A: Physicochem Eng Aspects 2006;287:217-221.
29. Blankespoor R, Limoges B, Schollhorn B, Magale JLS, Yazidi D. Dense monolayer of metal-chelating ligands covalently attached to carbon electrodes electrochemically and their useful application in affinity binding pf histidine-tagged proteins. Langmuir 2005;21:3362-3375. (Pubitemid 40552526)
30. Schartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
31. Kariuki JK, McDermott MT. Formation of multilayers on glassy carbon electrodes via th e reduction of diazonium salts. Langmuir 2001;17:5947-5951.